[Federal Register Volume 85, Number 40 (Friday, February 28, 2020)]
[Notices]
[Pages 11998-11999]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-04060]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Avenir Award Program for Research on Substance Abuse
and HIV/AIDS (DP2).
Date: March 13, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy
Chase, MD 20815.
Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer,
Office of Extramural Affairs, National Institute on Drug Abuse,
National Institutes of Health, 6001 Executive Boulevard, Room 4238,
MSC 9550, Bethesda, MD 20892, 301-402-6020, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; SEP II: Medications Development.
Date: March 19, 2020.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center
Building, 6001 Executive Boulevard, Room 4236, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Ivan K. Navarro, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, Division of
Extramural Research, National Institute on Drug Abuse, NIH, 6001
Executive Boulevard, Room 4242, MSC 9550, Bethesda, MD 20892, 301-
827-5833 [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIDA SEP for Medications Development.
Date: March 19, 2020.
Time: 2:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center
Building, 6001 Executive Boulevard, Room 4236, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Ivan K. Navarro, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, Division of
Extramural Research, National Institute on Drug Abuse, NIH, 6001
Executive Boulevard, Room 4242, MSC 9550, Bethesda, MD 20892, 301-
827-5833, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Modeling HIV Neuropathology Using Microglia from
Human iPSC and Cerebral Organoids (R01 Clinical Trial Not Allowed).
Date: March 25, 2020.
Time: 12:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center
Building, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Gerald L. McLaughlin, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, National Institute
on Drug Abuse, National Institutes of Health, 6001 Executive
Boulevard, Room
[[Page 11999]]
4235 MSC 9550, Bethesda, MD 20892-9550, 301-827-5819,
[email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Avenir Award Program for Genetics or Epigenetics of
Substance Use Disorders (DP1 Clinical Trial Optional).
Date: March 26, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Ivan K. Navarro, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, Division of
Extramural Research, National Institute on Drug Abuse, NIH, 6001
Executive Boulevard, Room 4242, MSC 9550, Bethesda, MD 20892, 301-
827-5833, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
Dated: February 24, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-04060 Filed 2-27-20; 8:45 am]
BILLING CODE 4140-01-P